[Federal Register Volume 82, Number 96 (Friday, May 19, 2017)]
[Notices]
[Pages 23070-23071]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-10240]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: American 
Radiolabeled Chemicals

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration in accordance with 21 CFR 
1301.33(a) on or before July 18, 2017.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DRW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION:  The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.

[[Page 23071]]

    In accordance with 21 CFR 1301.33(a), this is notice that on March 
7, 2017, American Radiolabeled Chemicals, Inc., 101 Arc Drive, Saint 
Louis, Missouri 63146 applied to be registered as a bulk manufacturer 
of the following basic classes of controlled substances:

------------------------------------------------------------------------
        Controlled substance            Drug code          Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid..........            2010  I
Ibogaine...........................            7260  I
Lysergic acid diethylamide.........            7315  I
Tetrahydrocannabinols..............            7370  I
Dimethyltryptamine.................            7435  I
1-[1-(2-                                       7470  I
 Thienyl)cyclohexyl]piperidine.
Dihydromorphine....................            9145  I
Heroin.............................            9200  I
Normorphine........................            9313  I
Amphetamine........................            1100  II
Methamphetamine....................            1105  II
Amobarbital........................            2125  II
Phencyclidine......................            7471  II
Phenylacetone......................            8501  II
Cocaine............................            9041  II
Codeine............................            9050  II
Dihydrocodeine.....................            9120  II
Oxycodone..........................            9143  II
Hydromorphone......................            9150  II
Ecgonine...........................            9180  II
Hydrocodone........................            9193  II
Meperidine.........................            9230  II
Metazocine.........................            9240  II
Methadone..........................            9250  II
Dextropropoxyphene, bulk (non-                 9273  II
 dosage forms).
Morphine...........................            9300  II
Oripavine..........................            9330  II
Thebaine...........................            9333  II
Oxymorphone........................            9652  II
Phenazocine........................            9715  II
Carfentanil........................            9743  II
Fentanyl...........................            9801  II
------------------------------------------------------------------------

    The company plans to manufacture small quantities of the listed 
controlled substances as radiolabeled compounds for biochemical 
research.

    Dated: May 15, 2017.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2017-10240 Filed 5-18-17; 8:45 am]
 BILLING CODE P